microdosing glp-1 for autoimmune GLP-1: A New Approach to Inflammation-Driven Diseases What Is Microdosing GLP-1s Like

Description

Stem Cell Therapies in Cardiovascular Disease

The E-Pharmacy Governance Vacuum The illegal supply chain is primarily enabled by a lack of regulation for online pharmacies

Whether youre starting or optimizing your weight loss journey, TrimRX offers personalized programs with expert consultations, tailored dosing, and ongoing support to help you achieve lasting results

However, it typically takes around 12 weeks to start noticing significant results

FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L